PFKFB4 and ovarian cancer: However, there is a lack of information regarding the exact concentration of paclitaxel that reaches the tumour, so although this work provides a useful insight into targeting PFKFB4 in mitotically arrested ovarian cancer cells, whether the nature of the mitotic arrest following paclitaxel treatment reflects that of an in vivo environment has yet to be established.